Towa Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -5.36% vs 12.65% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -233.42% vs 55.55% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "69,645.00",
          "val2": "73,589.00",
          "chgp": "-5.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9,662.00",
          "val2": "14,928.00",
          "chgp": "-35.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "580.00",
          "val2": "532.00",
          "chgp": "9.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-14,000.00",
          "val2": "3,023.00",
          "chgp": "-563.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11,832.00",
          "val2": "8,868.00",
          "chgp": "-233.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "51.80%",
          "val2": "123.00%",
          "chgp": "-7.12%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 5.44% vs 13.89% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -72.35% vs 17.39% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "273,710.00",
          "val2": "259,594.00",
          "chgp": "5.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "45,940.00",
          "val2": "43,342.00",
          "chgp": "5.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2,261.00",
          "val2": "1,627.00",
          "chgp": "38.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-9,422.00",
          "val2": "1,209.00",
          "chgp": "-879.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,250.00",
          "val2": "18,986.00",
          "chgp": "-72.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "84.40%",
          "val2": "89.50%",
          "chgp": "-0.51%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

69,645.00

73,589.00

-5.36%

Operating Profit (PBDIT) excl Other Income

9,662.00

14,928.00

-35.28%

Interest

580.00

532.00

9.02%

Exceptional Items

-14,000.00

3,023.00

-563.12%

Consolidate Net Profit

-11,832.00

8,868.00

-233.42%

Operating Profit Margin (Excl OI)

51.80%

123.00%

-7.12%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -5.36% vs 12.65% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -233.42% vs 55.55% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

273,710.00

259,594.00

5.44%

Operating Profit (PBDIT) excl Other Income

45,940.00

43,342.00

5.99%

Interest

2,261.00

1,627.00

38.97%

Exceptional Items

-9,422.00

1,209.00

-879.32%

Consolidate Net Profit

5,250.00

18,986.00

-72.35%

Operating Profit Margin (Excl OI)

84.40%

89.50%

-0.51%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 5.44% vs 13.89% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -72.35% vs 17.39% in Mar 2025

All Annual Results